🇺🇸 FDA
Patent

US 11027007

Recombinant metapneumovirus F proteins and their use

granted A61KA61K39/155A61K39/39

Quick answer

US patent 11027007 (Recombinant metapneumovirus F proteins and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61K, A61K39/155, A61K39/39, A61K48/00